Scholar Rock Holding (SRRK) | Stock Overview & Key Data
Scholar Rock Holding Performance Comparison
Stock Range
Today's Range
Low: $30.62
High: $32.53
on August 15, 2025
52 Week Range
Low: $6.76
High: $46.98
on October 3, 2024
on January 23, 2025
All-Time High: $70.00 on March 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$3.1B
EPS
-2.92
P/E Ratio (TTM)
-13.07
Forward P/E
-15.17
P/B Ratio
13.43
PEG Ratio
-0.21
Div. Yield
N/A
ROE
-172.08%
Beta
0.491
Debt to Equity
26.37
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
0.00%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-71.29%
Return on Equity (TTM)
-172.08%
EBITDA
$-321.7M
Net Income (TTM)
$-315.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
N/A
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Scholar Rock Holding SRRK | 3.14B Mid-cap | -1.69% | -18.96% | 1.88% | -14.99% | -28.87% | 237.02% | 232.73% | 130.45% |
| Vertex VRTX | 100.38B Large-cap | 7.15% | -15.40% | -9.59% | -15.01% | -3.21% | -17.72% | 31.35% | 44.79% |
| Regeneron REGN | 58.99B Large-cap | 3.09% | 5.92% | -0.78% | -14.65% | -18.85% | -50.78% | -6.14% | -4.14% |
| Moderna MRNA | 9.98B Mid-cap | 7.27% | -11.27% | 18.48% | -21.62% | -33.29% | -67.73% | -80.82% | -57.83% |
| BridgeBio Pharma BBIO | 9.38B Mid-cap | 10.18% | 9.26% | 52.10% | 44.60% | 81.99% | 110.33% | 394.89% | 82.18% |
| Blueprint Medicines BPMC | 8.37B Mid-cap | 0.12% | 1.05% | 53.79% | 15.63% | 48.46% | 12.60% | 149.54% | 73.38% |
Ownership & Short Interest
Insider Ownership
4.30%
Institutional Ownership
118.67%
Shares Short
15M
Short Ratio
12.73
Short % of Shares Outstanding
27.10%
Average 10-Day Volume
2M
Average 90-Day Volume
1M
Scholar Rock Holding Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Scholar Rock Holding would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SRRK's 52-week high and low?
- In the last 52 weeks, Scholar Rock Holding reached a high of $46.98 (on January 23, 2025) and a low of $6.76 (on October 3, 2024).
- What is the market cap and P/E ratio for SRRK?
- Curious about Scholar Rock Holding's size and valuation? Its market capitalization stands at 3.14B. When it comes to valuation, the P/E ratio (trailing twelve months) is -13.07, and the forward P/E (looking ahead) is -15.17.
- Does SRRK pay dividends? If so, what's the yield?
- As for dividends, Scholar Rock Holding isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Scholar Rock Holding's main competitors or similar companies to consider before investing?
When looking at Scholar Rock Holding, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX100.38B Healthcare Biotechnology -17.72% 31.35% Regeneron
REGN58.99B Healthcare Biotechnology -50.78% -6.14% Moderna
MRNA9.98B Healthcare Biotechnology -67.73% -80.82% BridgeBio Pharma
BBIO9.38B Healthcare Biotechnology 110.33% 394.89% Blueprint Medicines
BPMC8.37B Healthcare Biotechnology 12.60% 149.54% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Scholar Rock Holding Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Scholar Rock Holding's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -172.08%, the Debt to Equity ratio from the most recent quarter is 26.37, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for SRRK?
- Looking at Scholar Rock Holding's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of SRRK stock is held by insiders and institutions?
- Wondering who owns Scholar Rock Holding stock? Company insiders (like executives and directors) hold about 4.30% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 118.67%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.